Zdrowie i gospodarka · 05/09/2017

FDA Establishes Public Docket for Pediatric Post-Marketing Pharmacovigilance and Drug Utilization Reviews

The FDA is seeking public comments on the reviews of certain drugs posted between March 11, 2017, and September 12, 2017, which were not discussed at a Pediatric Advisory Committee meeting.